Published in Br J Pharmacol on July 09, 2007
Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis. JAMA (2008) 6.24
Antiasthmatic effects of hesperidin, a potential Th2 cytokine antagonist, in a mouse model of allergic asthma. Mediators Inflamm (2011) 0.96
Co-inhalation of roflumilast, rather than formoterol, with fluticasone more effectively improves asthma in asthmatic mice. Exp Biol Med (Maywood) (2017) 0.75
Synergy, additivism and antagonism in immunosuppression. A critical review. Clin Exp Immunol (1977) 2.89
Unrestrained plethysmography is an unreliable measure of airway responsiveness in BALB/c and C57BL/6 mice. J Appl Physiol (1985) (2004) 2.43
Enhanced synergy between fluticasone propionate and salmeterol inhaled from a single inhaler versus separate inhalers. J Allergy Clin Immunol (2003) 2.43
Interaction between glucocorticoids and beta2 agonists on bronchial airway smooth muscle cells through synchronised cellular signalling. Lancet (2002) 1.98
Glucocorticoid receptor nuclear translocation in airway cells after inhaled combination therapy. Am J Respir Crit Care Med (2005) 1.93
Ligand-independent activation of the glucocorticoid receptor by beta2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells. J Biol Chem (1999) 1.59
Effects of formoterol and budesonide on GM-CSF and IL-8 secretion by triggered human bronchial epithelial cells. Eur Respir J (2001) 1.57
The late, but not early, asthmatic response is dependent on IL-5 and correlates with eosinophil infiltration. J Clin Invest (1999) 1.56
Synergistic inhibition by beta(2)-agonists and corticosteroids on tumor necrosis factor-alpha-induced interleukin-8 release from cultured human airway smooth-muscle cells. Am J Respir Cell Mol Biol (2000) 1.16
Glucocorticosteroids increase beta 2-adrenergic receptor transcription in human lung. Am J Physiol (1995) 1.13
Is the neutrophil the key effector cell in severe asthma? Thorax (2005) 1.06
Effect of adenosine A2A receptor activation in murine models of respiratory disorders. Am J Physiol Lung Cell Mol Physiol (2005) 1.05
Advair: combination treatment with fluticasone propionate/salmeterol in the treatment of asthma. J Allergy Clin Immunol (2001) 1.01
Barometric whole body plethysmography in mice. J Appl Physiol (1985) (2005) 0.90
Glucocorticoids induce beta2-adrenergic receptor function in human nasal mucosa. Am J Respir Crit Care Med (1997) 0.87
Effects of formoterol on histamine induced plasma exudation in induced sputum from normal subjects. Thorax (1998) 0.87
Allergen challenge-induced extravasation of plasma in mouse airways. Clin Exp Allergy (1998) 0.85
A double-blind study on the effect of inhaled corticosteroids on plasma protein exudation in asthma. Am J Respir Crit Care Med (1999) 0.82
Intranasal salmeterol inhibits allergen-induced vascular permeability but not mast cell activation or cellular infiltration. Clin Exp Allergy (1998) 0.82
Symbicort Turbuhaler: a new concept in asthma management. Int J Clin Pract (2002) 0.81
Positive interaction of the beta2-agonist CHF 4226.01 with budesonide in the control of bronchoconstriction induced by acetaldehyde in the guinea-pigs. Br J Pharmacol (2005) 0.80
Enhanced synergy between fluticasone propionate and salmeterol inhaled from a single inhaler versus separate inhalers. J Allergy Clin Immunol (2004) 0.80
Seretide meta-analysis missed important features and overstates any advantages over concurrent LABA/ICS devices. J Allergy Clin Immunol (2004) 0.79
Phosphoinositide 3-kinase gamma: a key modulator in inflammation and allergy. Biochem Soc Trans (2003) 1.27
Effect of indacaterol, a novel long-acting beta2-agonist, on isolated human bronchi. Eur Respir J (2006) 1.16
Placental leptin in normal, diabetic and fetal growth-retarded pregnancies. Mol Hum Reprod (2000) 1.04
Activation of the Fas receptor on lung eosinophils leads to apoptosis and the resolution of eosinophilic inflammation of the airways. J Clin Invest (1995) 0.96
Endothelin receptor antagonists inhibit antigen-induced lung inflammation in mice. Am J Respir Crit Care Med (1997) 0.82
Activation of the lung S1P(1) receptor reduces allergen-induced plasma leakage in mice. Br J Pharmacol (2009) 0.81
Effects of WIN 64338, a nonpeptide bradykinin B2 receptor antagonist, on guinea-pig trachea. Br J Pharmacol (1995) 0.80
Association of guinea pig lung bombesin receptors with pertussis toxin-sensitive guanine nucleotide binding proteins. Eur J Pharmacol (1994) 0.78
Structural requirements for neuropeptide Y in mast cell and G protein activation. Eur J Pharmacol (1995) 0.77
Involvement of B2 receptors in the bradykinin-induced relaxation of guinea-pig isolated trachea. Br J Pharmacol (1995) 0.77
A pharmacogenetic study of ADRB2 polymorphisms and indacaterol response in COPD patients. Pharmacogenomics J (2011) 0.76
Bradykinin-induced contraction of human peripheral airways mediated by both bradykinin B2 and thromboxane prostanoid receptors. Am J Respir Crit Care Med (1995) 0.75
High-affinity receptors for bombesin-like peptides in normal guinea pig lung membranes. Life Sci (1991) 0.75
Bradykinin-induced contraction of guinea pig lung in vitro. Naunyn Schmiedebergs Arch Pharmacol (1994) 0.75
Heterogeneity of guinea-pig lung muscarinic receptors revealed by [3H]4-DAMP-binding. Pulm Pharmacol (1993) 0.75